Enterovirus infection can induce immune responses that cross‐react with β‐cell autoantigen tyrosine phosphatase IA‐2/IAR
- 4 January 2002
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 66 (3), 340-350
- https://doi.org/10.1002/jmv.2151
Abstract
Insulin-dependent (type 1) diabetes is characterized by progressive destruction of insulin-producing β cells probably by autoreactive T lymphocytes. Viral infections, especially those caused by coxsackieviruses, are postulated to play a role in the pathogenesis of the disease in humans. One mechanism by which viral infections could initiate or accelerate diabetogenic processes is “molecular mimicry,” induction of antiviral immune responses cross-reacting with epitopes in the β-cell autoantigens. Tyrosine phosphatases (IA-2, IAR) represent a major target autoantigen in type 1 diabetes. Both humoral and cellular immune responses are directed to the carboxy-terminal (C-terminal) part of the protein. This region has a 5-amino acid sequence identity, followed by five amino acid similarity with the conservative motif in the VP1-protein of enteroviruses (PALTAVETGA/HT), which is a highly immunogenic B- and T-cell epitope in enterovirus infection-induced immune responses. This observation prompted us to investigate potential humoral cross-reactions between immune responses induced by tyrosine phosphatases and enteroviruses. The reactivities of various peptide- and virus-induced rabbit antisera clearly demonstrated that cross-reactions do exist, and in both directions. Using epitope mapping, we were able to show that several diabetes-linked epitopes in IA-2 were also recognized by CBV-4-induced antisera. Immunization of female NOD-mice with formalin-inactivated purified strain of coxsackievirus B4 (CBV-4-E2) induced an immune response that recognized the IA-2/IAR diabetogenic peptide. The results obtained with human paired sera, collected during enterovirus infection, indicated that enterovirus infection in humans may also occasionally induce a humoral response that cross-reacts with IA-2/IAR. J. Med. Virol. 66:340-350, 2002.Keywords
Funding Information
- Maud Kuistila Memorial Foundation, Finland
- Sigrid Juselius Foundation, Helsinki, Finland
- Academy of Finland
- The Juvenile Diabetes Research Foundation, USA
- European Commission (BIOMED 2 Programme) (BMH4-CT98-3952)
This publication has 40 references indexed in Scilit:
- Acute Onset of Type I Diabetes Mellitus after Severe Echovirus 9 Infection: Putative Pathogenic PathwaysClinical Infectious Diseases, 2000
- Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4JCI Insight, 1999
- IA-2 and IA-2β: the immune response in IDDMDiabetes/Metabolism Research and Reviews, 1998
- Islet Cell Antibody Seroconversion in Children Is Temporally Associated with Enterovirus InfectionsThe Journal of Infectious Diseases, 1997
- IA-2 and IA-2β are Major Autoantigens in IDDM and the Precursors of the 40 kDa and 37 kDa Tryptic FragmentsJournal of Autoimmunity, 1996
- Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.JCI Insight, 1994
- T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele.The Journal of Experimental Medicine, 1994
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Insulin autoantibodies: Their role in the pathogenesis of IDDMDiabetes/Metabolism Research and Reviews, 1987
- Virus-Induced Diabetes MellitusNew England Journal of Medicine, 1979